… We hypothesized that the association between IgM anti-PC and the risk of CV outcome is
different in the presence of CV risk factors. We therefore further performed analyses within the …

… and coronary occlusion is the leading underlying cause of myocardial infarction and sudden
cardiac … Autoantibodies directed towards a variety of oxidation-specific epitopes or self—…

… could be related to the complexity of the LDL-oxidation process where antigens exposed
could vary to some extent, and there may also be differences in methods used for antibody …

… with the clinical outcomes. Potential immunomodulatory … antibody to target the root
causes of the inflammation and treat patients with early RA, thereby atherosclerosis and CVD…

… We also divided patients into inflamed C-reactive protein (CRP) > 5·6 mg/ml and non-inflamed
CRP. Antibody levels were determined by in-house enzyme-linked immunosorbent assay. …

Atherosclerosis and its main consequence, cardiovascular disease (CVD) are nowadays
regarded as chronic inflammatory disease conditions, and CVD is the main cause of death in …

… The antibody levels were used for cases vs controls and cross-disease analysis. Statistical …
for each antibody. The correlation between antibody level and cardiovascular score (CV) was …

… Because experimental evidence indicates that these autoantibodies could per se promote …
fact that we did not assess other auto-antibodies of potential CV relevance, which is outside of …

… are associated with negative cardiovascular outcomes. As a … the antibody circulating levels
and outcomes patients with CVD … The protective role of antibodies against phosphorylcholine …

… phosphocholine (POVPC); the antibody binding is tested for all known antigens that expose
PC. Capsular polysaccharide (C-PS), POVPC conjugated with bovine serum albumin (BSA), …